Aesthetics Biomedical (ABM) announces a distribution and marketing partnership with Plasma Concepts for the PlasmaMD and Plasma+, breakthrough German-manufactured, plasma energy devices, formerly known as Genesis and Revelation MD. By joining forces with the industry powerhouse ABM, PlasmaMD and Plasma+ will have expanded branding capabilities to showcase this new category of treatment while growing ABM’s strategic portfolio of devices and treatments that maximize results while enhancing the ultimate patient and provider experience. PlasmaMD and Plasma+ are FDA Class II cleared for soft tissue coagulation and lesion removal. The precise ARC in which the plasma energy is delivered to the skin, in both the PlasmaMD and Plasma+, helps combat the visible signs of facial aging. It is designed for skin rejuvenation that targets improvement in skin laxity, resurfacing texture, and the appearance of fine lines. “At the core of Aesthetics Biomedical our mission has and will always be to innovate and elevate the patient experience without sacrificing results," says states MaryAnn Guerra,president and CEO of Aesthetics Biomedical. "Our partnership with Plasma Concepts adds these leading plasma energy devices into our portfolio, addressing innovation in a relatively untapped category, but uniquely complementing our existing products of SoMESkincare, and Vivace RF Microneedle. This collection of devices further enhances the range of skincare treatments we offer with another proprietary technology. We are thrilled to work with the Plasma Concepts team to take advantage of the amazing sales skills and together bring these amazing devices to the provider!”
RELATED STORIES
What's New in Med Spa Products
4 Out Of 5 People Won't Visit Med Spas Without Safety Standards
Alastin Skincare Announces Issuance of Fourth U.S. Patent Incorporating TriHex Technology